Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roleca Juniper 100 mg for dyspeptic digestive complaints
2023-504750-35-01Phase 4Completed
- Sponsor
- Cell and Gene BioSolutions
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in functional dyspepsia (FD) comparing Roleca Wacholder 100 mg with Placebo (2 arms). Started Sep 2023; status: completed.
02
Drugs
Roleca Wacholder
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2023-504750-35-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504750-35-01.